Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Oropharyngeal Neoplasms × Chemoradiotherapy × Clear all

Phase

Status

Recruiting 5 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 6 Esophageal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Head and Neck Neoplasms 4 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lung Neoplasms 2 Glioblastoma 2 Carcinoma, Squamous Cell 2 Carcinoma 2 Adenocarcinoma 2 Tonsillar Neoplasms 1 Thrombocytopenia 1 Resectable Esophageal Cancer 1 Pharyngeal Neoplasms 1 Pain 1 Oropharyngeal Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Limited Stage Small Cell Lung Cancer 1 Irritable Bowel Syndrome 1 Colorectal Neoplasms 1 Carcinoma, Adenosquamous 1 Breast Neoplasms 1

Interventions

Radiotherapy 8 Cisplatin 7 Radiotherapy, Intensity-Modulated 6 Cetuximab 5 pembrolizumab 4 Radiation 3 Fluorouracil 3 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Vorinostat 2 Restraint, Physical 2 Psychiatric Rehabilitation 2 Polymerase Chain Reaction 2 Nivolumab 2 Immunohistochemistry 2 Gene Expression Profiling 2 Drug Therapy 2 Cyclophosphamide 2 Counseling 2 Celecoxib 2 Carboplatin 2 Bupropion 2 Blood Specimen Collection 2 Biopsy 2 motexafin gadolinium 1 iso-sulfan blue 1 ficlatuzumab 1 durvalumab 1 advexin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03838263 2025-03-04

IMMUNEBOOST

UNICANCER

Phase 2 Completed

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡